Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT02022709 Completed - Anxiety Disorders Clinical Trials

Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients

Start date: January 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficiency of SSRIs(Selective Serotonin Reuptake Inhibitor) ,ERP(Exposure and Response Prevention) and the combination of the two therapies for OCD(Obsessive-Compulsive Disorder) patients ,at the same time, to find out the biological or psychological predictors of treatment response in Chinese population.

NCT ID: NCT02018770 Unknown status - Clinical trials for Temporomandibular Disorder.

Effect of Phototherapy in Individuals With Temporomandibular Disorder.

Start date: January 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The present study aims to evaluate the effect of phototherapy with the combination of different sources of light on pain, activity of temporal and masseter muscles, bilateral and joint mobility in subjects with TMD. It will be made a randomized, placebo-controlled and double-blind clinical trial. Individuals participate with myogenic temporomandibular disorder, being allocated into 4 groups randomly and stratified by the method of sealed envelopes. The results will be evaluated using: RDC/TMD, digital caliper, electromyography, and visual analog scale and algometry. The protocols will be used in a single session and will be evaluated in four different moments. The variables that will be investigated are pain, muscle activity and joint mobility. The analyses of the data will be performed by adopting a significance level of 5%.

NCT ID: NCT02015143 Enrolling by invitation - Bipolar Disorder Clinical Trials

A Comprehensive Assessment and Follow up Descriptive Study on Bipolar Disorder

CAFE-BD
Start date: January 2012
Phase: N/A
Study type: Observational

The purpose of this study was to investigate the reliability and validity of the bipolar index (BPX) to diagnosis bipolar disorder, and to verify the stability of it in identifying bipolar disorder; the secondary purpose was to understand the dynamic changes of bipolar disorder in natural status.

NCT ID: NCT02013531 Completed - Anxiety Clinical Trials

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Start date: November 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of flexibly dosed adjunctive brexpiprazole treatment in subjects with major depressive disorder and anxiety symptoms, who are experiencing an inadequate selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) response.

NCT ID: NCT02010619 Completed - Clinical trials for Body Dysmorphic Disorder

Internet Delivered CBT for Body Dysmorphic Disorder

Start date: November 2013
Phase: N/A
Study type: Interventional

To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.

NCT ID: NCT02007447 Terminated - Clinical trials for Autism Spectrum Disorder

Oxytocin in Adolescents With Autism Spectrum Disorders

OXYASD
Start date: June 2015
Phase: Phase 2/Phase 3
Study type: Interventional

This study is design to evaluate the influence of oxytocin in some aspects of Autism Spectrum Disorder (ASD), such as, repetitive and stereotyped behavior, social skills, quality of life and disruptive behaviors. Null hypothesis: social skills, quality of life, disruptive behaviors and repetitive behaviors do not improve with the use of oxytocin. Experimental Hypothesis: social skills, quality of life, disruptive behaviors and repetitive and stereotyped behaviors improve with the use of oxytocin.

NCT ID: NCT02006199 Withdrawn - Clinical trials for Obsessive-compulsive Disorder

Effect of Mindfulness Based Treatment for Obsessive-compulsive Disorder

Start date: October 2013
Phase: N/A
Study type: Interventional

Hypothesis of this study is that mindfulness meditation would decrease the severity of obsessive-compulsive symptoms.

NCT ID: NCT02005367 Completed - Depression Clinical Trials

A Novel Person-Centered Treatment Component for Substance Use Treatment

Start date: June 2011
Phase: N/A
Study type: Interventional

A person-centered substance use treatment component, the Natural Recovery Program, was developed in a residential substance use treatment setting. The Natural Recovery Program is comprised of small group therapy combined with pursuit of hobbies. The study examined treatment retention, treatment completion and satisfaction of participants of Natural Recovery compared to those who participated in core residential treatment activities alone.

NCT ID: NCT02004743 Completed - Clinical trials for Post Traumatic Stress Disorder

Early Prevention of Post Traumatic Stress Disorder

Start date: January 2013
Phase: N/A
Study type: Interventional

Sunnybrook Health Sciences Centre is Canada's largest trauma centre, treating 1,100 patients annually. A traumatic experience can lead to post-traumatic stress disorder, which increases hospital stays, emergency visits and disability. Despite developing leadership to manage a "Code Orange" mass trauma, Sunnybrook lacks guidelines in the psychological management of patients who have experienced trauma. The department of psychiatry currently holds a Traumatic Brain Injury clinic and PTSD services for youth but lacks both immediate intervention, prevention and adult services. This research will enable us to gain best evidence expertise to develop guidelines as well as a sustainable PTSD treatment program, with clear outcomes to assess effectiveness, psychiatric morbidity, use of healthcare, disability and substance abuse. The five world-expert-consensus intervention resilience based principles will be operationalized in guidelines for the management of trauma patients, their caregivers and in routine nursing and trauma team care from the Emergency to the ward, and discharge, through to outpatient care. It is hypothesized that this will improve the psychological recovery of patients at risk of developing PTSD after a traumatic injury. In addition, early screening and intervention for increased risk of PTSD will be implemented one month after the trauma. It is hypothesized that such trauma informed psychological management, early screening and expert treatment using prolonged exposure will reduce hospital stays, functional disability, as well as longer-term psychiatric morbidity, including substance abuse.

NCT ID: NCT02003261 Completed - Anxiety Disorders Clinical Trials

Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP Study)

Start date: January 31, 2014
Phase: N/A
Study type: Interventional

This study is to examine the superiority of the combined treatments of transdiagnostic cognitive-behavior therapy (Unified Protocol; UP) and Treatment-As-Usual in comparison with the waiting-list with Treatment-As-Usual in the reduction of depressive and anxiety symptoms among depressive and anxiety disorders.